April 1, 2021
By Bio-IT World Staff
April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.
$969M Investment Fund for Early to Late-Stage Companies
Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market. Foresite Capital now has ~$4 billion in assets under management. Press release.
Your Say
Image credit http://end.org Child receiving medications by End Fund/Mo Scarpelli
Health is Wealth
Health is wealth, yet so many people are unable to benefit from it. Throughout the years, various research studies have examined the effect that healthy citizens have on a nation’s economic well-being. Recently, anew report by the Economist Intelligence Unit revealed that $3.2 billion in productivity could be gained between 2021 – 2040 by eliminating two neglected tropical diseases (NTDs), soil-transmitted helminths or intestinal worms and schistosomiasis (bilharzia) in Ethiopia – where at least 75 million people require treatment for at least one NTD.
NTDs are a group of parasitic, bacteria, and viral diseases that affect more than 1.7 billion people, particularly, the most vulnerable and marginalized people in society. Mass drug administration campaigns are conducted in disease endemic countries in order to reduce morbidity, which in turn contributes to an i
(Fron left) Benita Urey, CEO, The Liberia Influence; Macdella Cooper, Founder of the MAcdella Cooper Foundation; and Madam Ingrid Wetterqvist, Sweden Ambassador to Liberia; Grace Weah commonly known as Master Queen; and Antonio Turcott, Country Manager, DKT-Liberia at the launch of the Lydia Postpill Contraceptive Pill.
DKT-Liberia with support from the Sweden Embassy and the Ministry of Health/Family Health Division (MOH\FHD) has launched a contraceptive Postpill in celebration of the international day of women.
DKT International, a registered non-profit organization founded in 1989, is one of the world’s largest providers of contraceptives and safe abortion products. DKT International also seeks to mitigate the impending effects of COVID-19 on global access to contraceptives by adopting necessary preemptive measures.